194 related articles for article (PubMed ID: 8923035)
1. Molecular genetic alterations as intermediate end points in chemoprevention studies.
Conti CJ; Gimenez-Conti IB
IARC Sci Publ; 1996; (139):249-60. PubMed ID: 8923035
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in mouse lung tumors: implications for cancer chemoprevention.
Herzog CR; Lubet RA; You M
J Cell Biochem Suppl; 1997; 28-29():49-63. PubMed ID: 9589349
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer: chemoprevention and intermediate effect markers.
Tockman MS
IARC Sci Publ; 2001; 154():257-70. PubMed ID: 11220665
[TBL] [Abstract][Full Text] [Related]
5. [Progression of tumors: etiologic, morphologic and molecular-biological aspects].
Turosov VS
Arkh Patol; 1992; 54(7):5-14. PubMed ID: 1471943
[TBL] [Abstract][Full Text] [Related]
6. Mutations and altered expression of the human cancer genes: what they tell us about causes.
Devereux TR; Risinger JI; Barrett JC
IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
[TBL] [Abstract][Full Text] [Related]
7. Risk biomarkers and current strategies for cancer chemoprevention.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
9. The utility of genetically altered mouse models for nutrition and cancer chemoprevention research.
Hursting SD; Nunez NP; Patel AC; Perkins SN; Lubet RA; Barrett JC
Mutat Res; 2005 Aug; 576(1-2):80-92. PubMed ID: 15990122
[TBL] [Abstract][Full Text] [Related]
10. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis of pancreatic cancer.
Inoue S; Tezel E; Nakao A
Hepatogastroenterology; 2001; 48(40):933-8. PubMed ID: 11490843
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of oncogenes and tumor suppressor genes in human malignancy.
Spandidos DA; Liloglou T; Field JK
Stem Cells; 1993 May; 11(3):194-8. PubMed ID: 8318905
[TBL] [Abstract][Full Text] [Related]
13. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
14. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma.
Bäckvall H; Asplund A; Gustafsson A; Sivertsson A; Lundeberg J; Ponten F
Mutat Res; 2005 Apr; 571(1-2):65-79. PubMed ID: 15748639
[TBL] [Abstract][Full Text] [Related]
15. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
Bignold LP
Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
Osada H; Takahashi T
Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
Kelloff GJ; Sigman CC; Johnson KM; Boone CW; Greenwald P; Crowell JA; Hawk ET; Doody LA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):127-37. PubMed ID: 10698472
[TBL] [Abstract][Full Text] [Related]
18. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in upper aerodigestive tract tumorigenesis: a review.
Shin DM; Hittelman WN; Hong WK
Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):697-709. PubMed ID: 7881344
[TBL] [Abstract][Full Text] [Related]
20. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
